SAVA Deadline: SAVA Investors Have Opportunity to Lead Cassava Sciences, Inc. Securities Fraud Lawsuit
1. Cassava Sciences faces a class action lawsuit for misleading investors. 2. The lawsuit addresses false information about drug prospects and risks. 3. Investors may seek compensation without upfront fees via contingency arrangements. 4. A lead plaintiff must be established by February 10, 2025. 5. Rosen Law Firm has a history of successful securities class actions.